Clinical Trial Update: Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 trial of bortezomib (Velcade) in combination with dexamethasone for relapsed Hodgkin lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Decadron (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin Disease | Phase 2 | Status: TERMINATED